MedPath

Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen

Phase 2
Completed
Conditions
Alzheimer's Disease
Registration Number
NCT00018343
Lead Sponsor
US Department of Veterans Affairs
Brief Summary

This study is designed to evaluate the potential beneficial effects of estrogen on cognitive function of women with Alzheimer's Disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

VA Puget Sound Health Care System

🇺🇸

Lakewood, Washington, United States

VA Puget Sound Health Care System
🇺🇸Lakewood, Washington, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.